AU2016205208A1 - Methods and compositions for ebola virus vaccination - Google Patents

Info

Publication number

AU2016205208A1

AU2016205208A1 AU2016205208A AU2016205208A AU2016205208A1 AU 2016205208 A1 AU2016205208 A1 AU 2016205208A1 AU 2016205208 A AU2016205208 A AU 2016205208A AU 2016205208 A AU2016205208 A AU 2016205208A AU 2016205208 A1 AU2016205208 A1 AU 2016205208A1

Authority

AU

Australia

Prior art keywords

ebola virus

seq

virus antigen

composition

antigen

Prior art date

2015-01-09

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims abstract description 179
• 241001115402 Ebolavirus Species 0.000 title claims abstract description 175
• 239000000203 mixture Substances 0.000 title claims description 204
• 238000002255 vaccination Methods 0.000 title abstract description 20
• 239000013598 vector Substances 0.000 claims abstract description 544
• 108091007433 antigens Proteins 0.000 claims abstract description 387
• 102000036639 antigens Human genes 0.000 claims abstract description 387
• 239000000427 antigen Substances 0.000 claims abstract description 374
• 241000701161 unidentified adenovirus Species 0.000 claims abstract description 225
• 230000028993 immune response Effects 0.000 claims abstract description 175
• 241001135569 Human adenovirus 5 Species 0.000 claims description 268
• 210000004027 cell Anatomy 0.000 claims description 229
• 108090000623 proteins and genes Proteins 0.000 claims description 222
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 claims description 149
• 238000012217 deletion Methods 0.000 claims description 139
• 230000037430 deletion Effects 0.000 claims description 139
• 230000010076 replication Effects 0.000 claims description 129
• 241000282414 Homo sapiens Species 0.000 claims description 123
• 230000002950 deficient Effects 0.000 claims description 112
• 102000004169 proteins and genes Human genes 0.000 claims description 104
• 150000007523 nucleic acids Chemical group 0.000 claims description 84
• 230000014509 gene expression Effects 0.000 claims description 79
• 230000002163 immunogen Effects 0.000 claims description 54
• 102000039446 nucleic acids Human genes 0.000 claims description 53
• 108020004707 nucleic acids Proteins 0.000 claims description 53
• 241000700605 Viruses Species 0.000 claims description 50
• 239000002245 particle Substances 0.000 claims description 46
• 210000004443 dendritic cell Anatomy 0.000 claims description 43
• 230000001965 increasing effect Effects 0.000 claims description 34
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 33
• 108010002586 Interleukin-7 Proteins 0.000 claims description 32
• 241000884921 Bundibugyo ebolavirus Species 0.000 claims description 31
• 241001115394 Reston ebolavirus Species 0.000 claims description 30
• 238000011282 treatment Methods 0.000 claims description 30
• 241001115374 Tai Forest ebolavirus Species 0.000 claims description 28
• 238000009169 immunotherapy Methods 0.000 claims description 28
• 230000003472 neutralizing effect Effects 0.000 claims description 28
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 27
• 102100037850 Interferon gamma Human genes 0.000 claims description 25
• 108010074328 Interferon-gamma Proteins 0.000 claims description 25
• 230000001225 therapeutic effect Effects 0.000 claims description 24
• 238000003556 assay Methods 0.000 claims description 22
• 230000001939 inductive effect Effects 0.000 claims description 22
• 230000004048 modification Effects 0.000 claims description 21
• 238000012986 modification Methods 0.000 claims description 21
• -1 immune therapies Substances 0.000 claims description 20
• 150000001413 amino acids Chemical class 0.000 claims description 19
• 108010002350 Interleukin-2 Proteins 0.000 claims description 18
• 102000000588 Interleukin-2 Human genes 0.000 claims description 18
• 230000024932 T cell mediated immunity Effects 0.000 claims description 16
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims description 16
• 102000004127 Cytokines Human genes 0.000 claims description 15
• 108090000695 Cytokines Proteins 0.000 claims description 15
• 230000028327 secretion Effects 0.000 claims description 14
• 108090000174 Interleukin-10 Proteins 0.000 claims description 12
• 108010065805 Interleukin-12 Proteins 0.000 claims description 12
• 108090000176 Interleukin-13 Proteins 0.000 claims description 12
• 108010002386 Interleukin-3 Proteins 0.000 claims description 12
• 108090000978 Interleukin-4 Proteins 0.000 claims description 12
• 108010002616 Interleukin-5 Proteins 0.000 claims description 12
• 108090001005 Interleukin-6 Proteins 0.000 claims description 12
• 108090001007 Interleukin-8 Proteins 0.000 claims description 12
• 108010002335 Interleukin-9 Proteins 0.000 claims description 12
• 230000008350 antigen-specific antibody response Effects 0.000 claims description 12
• 108090000171 Interleukin-18 Proteins 0.000 claims description 11
• 108700012920 TNF Proteins 0.000 claims description 11
• 210000000612 antigen-presenting cell Anatomy 0.000 claims description 11
• 230000006037 cell lysis Effects 0.000 claims description 7
• 238000002560 therapeutic procedure Methods 0.000 claims description 7
• WEYNBWVKOYCCQT-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(=O)NC1=CC=C(C)C(Cl)=C1 WEYNBWVKOYCCQT-UHFFFAOYSA-N 0.000 claims description 6
• 101710137115 Adenylyl cyclase-associated protein 1 Proteins 0.000 claims description 6
• 101150005585 E3 gene Proteins 0.000 claims description 6
• 101150066038 E4 gene Proteins 0.000 claims description 6
• 230000000735 allogeneic effect Effects 0.000 claims description 6
• 239000003814 drug Substances 0.000 claims description 6
• 229940079593 drug Drugs 0.000 claims description 6
• 150000003431 steroids Chemical class 0.000 claims description 6
• 210000002865 immune cell Anatomy 0.000 claims description 5
• 239000003246 corticosteroid Substances 0.000 claims description 4
• 229960001334 corticosteroids Drugs 0.000 claims description 4
• 239000003018 immunosuppressive agent Substances 0.000 claims description 4
• 229940125721 immunosuppressive agent Drugs 0.000 claims description 4
• 230000002018 overexpression Effects 0.000 claims description 4
• 208000024891 symptom Diseases 0.000 claims description 4
• 230000001771 impaired effect Effects 0.000 claims description 3
• WAVYAFBQOXCGSZ-UHFFFAOYSA-N 2-fluoropyrimidine Chemical compound FC1=NC=CC=N1 WAVYAFBQOXCGSZ-UHFFFAOYSA-N 0.000 claims description 2
• 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 2
• 208000023275 Autoimmune disease Diseases 0.000 claims description 2
• GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims description 2
• GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims description 2
• 206010012735 Diarrhoea Diseases 0.000 claims description 2
• 208000010201 Exanthema Diseases 0.000 claims description 2
• 206010019233 Headaches Diseases 0.000 claims description 2
• 208000032843 Hemorrhage Diseases 0.000 claims description 2
• 206010019799 Hepatitis viral Diseases 0.000 claims description 2
• 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 2
• 239000002138 L01XE21 - Regorafenib Substances 0.000 claims description 2
• 229930192392 Mitomycin Natural products 0.000 claims description 2
• 208000000112 Myalgia Diseases 0.000 claims description 2
• NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 claims description 2
• 206010068319 Oropharyngeal pain Diseases 0.000 claims description 2
• 201000007100 Pharyngitis Diseases 0.000 claims description 2
• 206010037660 Pyrexia Diseases 0.000 claims description 2
• 206010039710 Scleroderma Diseases 0.000 claims description 2
• 208000024799 Thyroid disease Diseases 0.000 claims description 2
• 206010047642 Vitiligo Diseases 0.000 claims description 2
• 206010047700 Vomiting Diseases 0.000 claims description 2
• 230000001363 autoimmune Effects 0.000 claims description 2
• 230000000740 bleeding effect Effects 0.000 claims description 2
• 239000010836 blood and blood product Substances 0.000 claims description 2
• 210000000601 blood cell Anatomy 0.000 claims description 2
• 229940125691 blood product Drugs 0.000 claims description 2
• 229960004117 capecitabine Drugs 0.000 claims description 2
• 238000002512 chemotherapy Methods 0.000 claims description 2
• 210000000981 epithelium Anatomy 0.000 claims description 2
• 201000005884 exanthem Diseases 0.000 claims description 2
• 206010016256 fatigue Diseases 0.000 claims description 2
• 239000012530 fluid Substances 0.000 claims description 2
• 231100000869 headache Toxicity 0.000 claims description 2
• 238000001990 intravenous administration Methods 0.000 claims description 2
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 claims description 2
• 229960004768 irinotecan Drugs 0.000 claims description 2
• 210000003734 kidney Anatomy 0.000 claims description 2
• 230000003907 kidney function Effects 0.000 claims description 2
• 230000003908 liver function Effects 0.000 claims description 2
• 229960004857 mitomycin Drugs 0.000 claims description 2
• 201000006417 multiple sclerosis Diseases 0.000 claims description 2
• 208000013465 muscle pain Diseases 0.000 claims description 2
• DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 claims description 2
• 229960001756 oxaliplatin Drugs 0.000 claims description 2
• 229960001972 panitumumab Drugs 0.000 claims description 2
• 238000001959 radiotherapy Methods 0.000 claims description 2
• 206010037844 rash Diseases 0.000 claims description 2
• 229960004836 regorafenib Drugs 0.000 claims description 2
• FNHKPVJBJVTLMP-UHFFFAOYSA-N regorafenib Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=C(F)C(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 FNHKPVJBJVTLMP-UHFFFAOYSA-N 0.000 claims description 2
• 238000007920 subcutaneous administration Methods 0.000 claims description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 claims description 2
• 208000021510 thyroid gland disease Diseases 0.000 claims description 2
• 201000001862 viral hepatitis Diseases 0.000 claims description 2
• 230000008673 vomiting Effects 0.000 claims description 2
• 102100027241 Adenylyl cyclase-associated protein 1 Human genes 0.000 claims 3
• 230000036039 immunity Effects 0.000 abstract description 44
• 229960005486 vaccine Drugs 0.000 description 110
• 235000018102 proteins Nutrition 0.000 description 93
• 108090000765 processed proteins & peptides Proteins 0.000 description 84
• 102000004196 processed proteins & peptides Human genes 0.000 description 81
• 229920001184 polypeptide Polymers 0.000 description 79
• 102000003886 Glycoproteins Human genes 0.000 description 60
• 108090000288 Glycoproteins Proteins 0.000 description 60
• 239000012634 fragment Substances 0.000 description 57
• 102000011931 Nucleoproteins Human genes 0.000 description 55
• 108010061100 Nucleoproteins Proteins 0.000 description 55
• 101150010086 VP24 gene Proteins 0.000 description 51
• 101150026858 VP30 gene Proteins 0.000 description 51
• 101150077651 VP35 gene Proteins 0.000 description 51
• 101150036892 VP40 gene Proteins 0.000 description 50
• 102000040430 polynucleotide Human genes 0.000 description 49
• 108091033319 polynucleotide Proteins 0.000 description 49
• 239000002157 polynucleotide Substances 0.000 description 49
• 101710164463 Preterminal protein Proteins 0.000 description 35
• 238000002649 immunization Methods 0.000 description 35
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 34
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 33
• 230000000694 effects Effects 0.000 description 33
• 230000003053 immunization Effects 0.000 description 32
• 210000002845 virion Anatomy 0.000 description 31
• 230000004044 response Effects 0.000 description 30
• 230000006870 function Effects 0.000 description 29
• 230000003612 virological effect Effects 0.000 description 29
• 241001115376 Sudan ebolavirus Species 0.000 description 28
• 208000015181 infectious disease Diseases 0.000 description 28
• 239000000047 product Substances 0.000 description 27
• 230000035772 mutation Effects 0.000 description 24
• 238000011220 combination immunotherapy Methods 0.000 description 22
• 239000013603 viral vector Substances 0.000 description 22
• 239000002585 base Substances 0.000 description 21
• 230000008901 benefit Effects 0.000 description 21
• 102100040678 Programmed cell death protein 1 Human genes 0.000 description 20
• 239000002773 nucleotide Substances 0.000 description 20
• 125000003729 nucleotide group Chemical group 0.000 description 20
• 108020004414 DNA Proteins 0.000 description 19
• 108700019146 Transgenes Proteins 0.000 description 19
• 108010067390 Viral Proteins Proteins 0.000 description 19
• 230000004927 fusion Effects 0.000 description 19
• 241000711408 Murine respirovirus Species 0.000 description 18
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 18
• 238000013518 transcription Methods 0.000 description 18
• 230000035897 transcription Effects 0.000 description 18
• 235000001014 amino acid Nutrition 0.000 description 17
• 230000005847 immunogenicity Effects 0.000 description 17
• 108091008036 Immune checkpoint proteins Proteins 0.000 description 16
• 241000699670 Mus sp. Species 0.000 description 16
• 230000008088 immune pathway Effects 0.000 description 16
• 230000002829 reductive effect Effects 0.000 description 16
• 108010074708 B7-H1 Antigen Proteins 0.000 description 15
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 15
• 238000004519 manufacturing process Methods 0.000 description 15
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 14
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 14
• 241000282412 Homo Species 0.000 description 14
• 102000037982 Immune checkpoint proteins Human genes 0.000 description 14
• 238000013459 approach Methods 0.000 description 14
• 230000002401 inhibitory effect Effects 0.000 description 14
• 102000005962 receptors Human genes 0.000 description 14
• 108020003175 receptors Proteins 0.000 description 14
• 230000004083 survival effect Effects 0.000 description 14
• 241001430294 unidentified retrovirus Species 0.000 description 14
• 230000006698 induction Effects 0.000 description 13
• 230000001404 mediated effect Effects 0.000 description 13
• 230000037361 pathway Effects 0.000 description 13
• 241000713666 Lentivirus Species 0.000 description 12
• 239000000835 fiber Substances 0.000 description 12
• 230000035800 maturation Effects 0.000 description 12
• 230000010415 tropism Effects 0.000 description 12
• 241001465754 Metazoa Species 0.000 description 11
• 125000003275 alpha amino acid group Chemical group 0.000 description 11
• 229940024606 amino acid Drugs 0.000 description 11
• 239000000243 solution Substances 0.000 description 11
• 101710172711 Structural protein Proteins 0.000 description 10
• 230000003247 decreasing effect Effects 0.000 description 10
• 238000004806 packaging method and process Methods 0.000 description 10
• 230000001105 regulatory effect Effects 0.000 description 10
• 238000006467 substitution reaction Methods 0.000 description 10
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 9
• 230000001976 improved effect Effects 0.000 description 9
• 238000002347 injection Methods 0.000 description 9
• 239000007924 injection Substances 0.000 description 9
• 230000003389 potentiating effect Effects 0.000 description 9
• 238000013519 translation Methods 0.000 description 9
• 229940126580 vector vaccine Drugs 0.000 description 9
• 108020004705 Codon Proteins 0.000 description 8
• 206010061218 Inflammation Diseases 0.000 description 8
• 241000580858 Simian-Human immunodeficiency virus Species 0.000 description 8
• 230000004888 barrier function Effects 0.000 description 8
• 210000000234 capsid Anatomy 0.000 description 8
• 230000001413 cellular effect Effects 0.000 description 8
• 201000010099 disease Diseases 0.000 description 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
• 230000002708 enhancing effect Effects 0.000 description 8
• 230000004054 inflammatory process Effects 0.000 description 8
• 238000003780 insertion Methods 0.000 description 8
• 230000037431 insertion Effects 0.000 description 8
• 238000010361 transduction Methods 0.000 description 8
• 230000026683 transduction Effects 0.000 description 8
• 108090000565 Capsid Proteins Proteins 0.000 description 7
• 102100023321 Ceruloplasmin Human genes 0.000 description 7
• 108091026890 Coding region Proteins 0.000 description 7
• 230000004543 DNA replication Effects 0.000 description 7
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 7
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 7
• 102000017578 LAG3 Human genes 0.000 description 7
• 206010028980 Neoplasm Diseases 0.000 description 7
• 230000005867 T cell response Effects 0.000 description 7
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 7
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 7
• 238000007792 addition Methods 0.000 description 7
• 230000008859 change Effects 0.000 description 7
• 229940001442 combination vaccine Drugs 0.000 description 7
• 230000007423 decrease Effects 0.000 description 7
• 230000001900 immune effect Effects 0.000 description 7
• 230000003993 interaction Effects 0.000 description 7
• 230000007246 mechanism Effects 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 210000001519 tissue Anatomy 0.000 description 7
• 231100000331 toxic Toxicity 0.000 description 7
• 230000002588 toxic effect Effects 0.000 description 7
• 238000012384 transportation and delivery Methods 0.000 description 7
• 101710094648 Coat protein Proteins 0.000 description 6
• 241000701022 Cytomegalovirus Species 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 description 6
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 6
• 108091008874 T cell receptors Proteins 0.000 description 6
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 6
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 6
• 230000001419 dependent effect Effects 0.000 description 6
• 230000003292 diminished effect Effects 0.000 description 6
• 238000001476 gene delivery Methods 0.000 description 6
• 102000006495 integrins Human genes 0.000 description 6
• 108010044426 integrins Proteins 0.000 description 6
• 230000004853 protein function Effects 0.000 description 6
• 229940023835 Ad-based vaccine Drugs 0.000 description 5
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 description 5
• 102100038078 CD276 antigen Human genes 0.000 description 5
• 101150013553 CD40 gene Proteins 0.000 description 5
• 102000053602 DNA Human genes 0.000 description 5
• 206010061818 Disease progression Diseases 0.000 description 5
• 229940124722 Ebola vaccine Drugs 0.000 description 5
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
• 101710155188 Hexon-interlacing protein Proteins 0.000 description 5
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 description 5
• 230000006044 T cell activation Effects 0.000 description 5
• 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 210000003719 b-lymphocyte Anatomy 0.000 description 5
• 230000005750 disease progression Effects 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 230000001024 immunotherapeutic effect Effects 0.000 description 5
• 230000028709 inflammatory response Effects 0.000 description 5
• 210000000056 organ Anatomy 0.000 description 5
• 238000003752 polymerase chain reaction Methods 0.000 description 5
• 230000011664 signaling Effects 0.000 description 5
• 229940021747 therapeutic vaccine Drugs 0.000 description 5
• 101710185679 CD276 antigen Proteins 0.000 description 4
• 229940045513 CTLA4 antagonist Drugs 0.000 description 4
• 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 4
• 241000450599 DNA viruses Species 0.000 description 4
• 108700024394 Exon Proteins 0.000 description 4
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 4
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 4
• 101001068133 Homo sapiens Hepatitis A virus cellular receptor 2 Proteins 0.000 description 4
• 108060004795 Methyltransferase Proteins 0.000 description 4
• 108091005804 Peptidases Proteins 0.000 description 4
• 108700008625 Reporter Genes Proteins 0.000 description 4
• 108010079206 V-Set Domain-Containing T-Cell Activation Inhibitor 1 Proteins 0.000 description 4
• 108020005202 Viral DNA Proteins 0.000 description 4
• 108700005077 Viral Genes Proteins 0.000 description 4
• 230000000890 antigenic effect Effects 0.000 description 4
• 230000027455 binding Effects 0.000 description 4
• 238000011161 development Methods 0.000 description 4
• 108020001507 fusion proteins Proteins 0.000 description 4
• 102000037865 fusion proteins Human genes 0.000 description 4
• 239000005090 green fluorescent protein Substances 0.000 description 4
• 238000001727 in vivo Methods 0.000 description 4
• 230000015788 innate immune response Effects 0.000 description 4
• 238000011835 investigation Methods 0.000 description 4
• 239000003446 ligand Substances 0.000 description 4
• 239000013612 plasmid Substances 0.000 description 4
• 230000004224 protection Effects 0.000 description 4
• 238000000746 purification Methods 0.000 description 4
• 238000010188 recombinant method Methods 0.000 description 4
• 238000001890 transfection Methods 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 230000029812 viral genome replication Effects 0.000 description 4
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 3
• 206010067484 Adverse reaction Diseases 0.000 description 3
• 108700028369 Alleles Proteins 0.000 description 3
• 241000283690 Bos taurus Species 0.000 description 3
• 108010029697 CD40 Ligand Proteins 0.000 description 3
• 102100032937 CD40 ligand Human genes 0.000 description 3
• VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
• 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 3
• 102000004190 Enzymes Human genes 0.000 description 3
• 108090000790 Enzymes Proteins 0.000 description 3
• 241000588724 Escherichia coli Species 0.000 description 3
• 102100029951 Estrogen receptor beta Human genes 0.000 description 3
• 101710145505 Fiber protein Proteins 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 241001183012 Modified Vaccinia Ankara virus Species 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 101710188053 Protein D Proteins 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 101710132893 Resolvase Proteins 0.000 description 3
• 230000006052 T cell proliferation Effects 0.000 description 3
• 102100033082 TNF receptor-associated factor 3 Human genes 0.000 description 3
• 108010003533 Viral Envelope Proteins Proteins 0.000 description 3
• 230000006838 adverse reaction Effects 0.000 description 3
• 230000005809 anti-tumor immunity Effects 0.000 description 3
• 230000004071 biological effect Effects 0.000 description 3
• 210000001185 bone marrow Anatomy 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• 238000001516 cell proliferation assay Methods 0.000 description 3
• 229910052804 chromium Inorganic materials 0.000 description 3
• 239000011651 chromium Substances 0.000 description 3
• 238000010367 cloning Methods 0.000 description 3
• 230000000875 corresponding effect Effects 0.000 description 3
• 230000001186 cumulative effect Effects 0.000 description 3
• 230000009089 cytolysis Effects 0.000 description 3
• 229940088598 enzyme Drugs 0.000 description 3
• 238000009472 formulation Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• 230000012010 growth Effects 0.000 description 3
• 210000003494 hepatocyte Anatomy 0.000 description 3
• 229940126546 immune checkpoint molecule Drugs 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 230000007774 longterm Effects 0.000 description 3
• 230000001589 lymphoproliferative effect Effects 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 210000004379 membrane Anatomy 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 238000002703 mutagenesis Methods 0.000 description 3
• 231100000350 mutagenesis Toxicity 0.000 description 3
• 230000008569 process Effects 0.000 description 3
• 230000000644 propagated effect Effects 0.000 description 3
• 230000009257 reactivity Effects 0.000 description 3
• 230000006798 recombination Effects 0.000 description 3
• 230000001177 retroviral effect Effects 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 231100000827 tissue damage Toxicity 0.000 description 3
• 230000000451 tissue damage Effects 0.000 description 3
• 230000002103 transcriptional effect Effects 0.000 description 3
• 210000004881 tumor cell Anatomy 0.000 description 3
• ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 2
• CXURGFRDGROIKG-UHFFFAOYSA-N 3,3-bis(chloromethyl)oxetane Chemical compound ClCC1(CCl)COC1 CXURGFRDGROIKG-UHFFFAOYSA-N 0.000 description 2
• 102000007469 Actins Human genes 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 2
• 241000701242 Adenoviridae Species 0.000 description 2
• 208000010370 Adenoviridae Infections Diseases 0.000 description 2
• 206010060931 Adenovirus infection Diseases 0.000 description 2
• 108700023418 Amidases Proteins 0.000 description 2
• 241000271566 Aves Species 0.000 description 2
• 241000193738 Bacillus anthracis Species 0.000 description 2
• 102100024263 CD160 antigen Human genes 0.000 description 2
• 102100027207 CD27 antigen Human genes 0.000 description 2
• 102100025221 CD70 antigen Human genes 0.000 description 2
• 102100035793 CD83 antigen Human genes 0.000 description 2
• 101710198223 Capsid fiber protein Proteins 0.000 description 2
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 241000702421 Dependoparvovirus Species 0.000 description 2
• 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 2
• 101710121417 Envelope glycoprotein Proteins 0.000 description 2
• 108091008794 FGF receptors Proteins 0.000 description 2
• 102000044168 Fibroblast Growth Factor Receptor Human genes 0.000 description 2
• 241000711950 Filoviridae Species 0.000 description 2
• 102100031351 Galectin-9 Human genes 0.000 description 2
• 241000272496 Galliformes Species 0.000 description 2
• 101100229077 Gallus gallus GAL9 gene Proteins 0.000 description 2
• 206010019851 Hepatotoxicity Diseases 0.000 description 2
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 2
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 2
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 2
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 2
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 2
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 2
• 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 2
• 101001117312 Homo sapiens Programmed cell death 1 ligand 2 Proteins 0.000 description 2
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 2
• 101000716124 Homo sapiens T-cell surface glycoprotein CD1c Proteins 0.000 description 2
• 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 description 2
• 102000002265 Human Growth Hormone Human genes 0.000 description 2
• 108010000521 Human Growth Hormone Proteins 0.000 description 2
• 239000000854 Human Growth Hormone Substances 0.000 description 2
• 102100034980 ICOS ligand Human genes 0.000 description 2
• 101150032643 IVa2 gene Proteins 0.000 description 2
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 description 2
• 102100034349 Integrase Human genes 0.000 description 2
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 2
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 108010043610 KIR Receptors Proteins 0.000 description 2
• 102100033627 Killer cell immunoglobulin-like receptor 3DL1 Human genes 0.000 description 2
• 101150062031 L gene Proteins 0.000 description 2
• 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 2
• 102000043129 MHC class I family Human genes 0.000 description 2
• 108091054437 MHC class I family Proteins 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 102000000440 Melanoma-associated antigen Human genes 0.000 description 2
• 108050008953 Melanoma-associated antigen Proteins 0.000 description 2
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 241000713869 Moloney murine leukemia virus Species 0.000 description 2
• 102100034256 Mucin-1 Human genes 0.000 description 2
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 2
• 102000004473 OX40 Ligand Human genes 0.000 description 2
• 108010042215 OX40 Ligand Proteins 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 108010058846 Ovalbumin Proteins 0.000 description 2
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 2
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 2
• 239000004365 Protease Substances 0.000 description 2
• 101710194807 Protective antigen Proteins 0.000 description 2
• 101710149951 Protein Tat Proteins 0.000 description 2
• 108091027981 Response element Proteins 0.000 description 2
• 102000004389 Ribonucleoproteins Human genes 0.000 description 2
• 108010081734 Ribonucleoproteins Proteins 0.000 description 2
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
• 108020004459 Small interfering RNA Proteins 0.000 description 2
• 206010042566 Superinfection Diseases 0.000 description 2
• 102100024219 T-cell surface glycoprotein CD1a Human genes 0.000 description 2
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 2
• 241000723873 Tobacco mosaic virus Species 0.000 description 2
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 2
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 2
• 101710165474 Tumor necrosis factor receptor superfamily member 5 Proteins 0.000 description 2
• 102000016540 Tyrosine aminotransferases Human genes 0.000 description 2
• 108010042606 Tyrosine transaminase Proteins 0.000 description 2
• 108091008605 VEGF receptors Proteins 0.000 description 2
• 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 description 2
• 108010087302 Viral Structural Proteins Proteins 0.000 description 2
• 208000036142 Viral infection Diseases 0.000 description 2
• 239000012082 adaptor molecule Substances 0.000 description 2
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
• 208000011589 adenoviridae infectious disease Diseases 0.000 description 2
• 108700010877 adenoviridae proteins Proteins 0.000 description 2
• 230000004075 alteration Effects 0.000 description 2
• 102000005922 amidase Human genes 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 230000003263 anti-adenoviral effect Effects 0.000 description 2
• 230000000844 anti-bacterial effect Effects 0.000 description 2
• 230000002141 anti-parasite Effects 0.000 description 2
• 230000000692 anti-sense effect Effects 0.000 description 2
• 230000000840 anti-viral effect Effects 0.000 description 2
• 230000030741 antigen processing and presentation Effects 0.000 description 2
• 239000003096 antiparasitic agent Substances 0.000 description 2
• 230000005975 antitumor immune response Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 108010005774 beta-Galactosidase Proteins 0.000 description 2
• 230000005540 biological transmission Effects 0.000 description 2
• 210000004900 c-terminal fragment Anatomy 0.000 description 2
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 238000005119 centrifugation Methods 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 230000002089 crippling effect Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 230000001627 detrimental effect Effects 0.000 description 2
• 230000003828 downregulation Effects 0.000 description 2
• 241001493065 dsRNA viruses Species 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 238000010195 expression analysis Methods 0.000 description 2
• 239000013604 expression vector Substances 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 210000004602 germ cell Anatomy 0.000 description 2
• 231100000304 hepatotoxicity Toxicity 0.000 description 2
• 230000007686 hepatotoxicity Effects 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000004727 humoral immunity Effects 0.000 description 2
• 238000009396 hybridization Methods 0.000 description 2
• 230000008073 immune recognition Effects 0.000 description 2
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 230000002458 infectious effect Effects 0.000 description 2
• 239000003112 inhibitor Substances 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000002743 insertional mutagenesis Methods 0.000 description 2
• 229940079322 interferon Drugs 0.000 description 2
• 230000019734 interleukin-12 production Effects 0.000 description 2
• 230000002601 intratumoral effect Effects 0.000 description 2
• 210000004185 liver Anatomy 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 210000004779 membrane envelope Anatomy 0.000 description 2
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 210000004296 naive t lymphocyte Anatomy 0.000 description 2
• 230000001613 neoplastic effect Effects 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 230000003287 optical effect Effects 0.000 description 2
• 230000036961 partial effect Effects 0.000 description 2
• 210000005259 peripheral blood Anatomy 0.000 description 2
• 239000011886 peripheral blood Substances 0.000 description 2
• 230000037452 priming Effects 0.000 description 2
• 108010042121 probasin Proteins 0.000 description 2
• 230000035755 proliferation Effects 0.000 description 2
• 230000001902 propagating effect Effects 0.000 description 2
• 230000001681 protective effect Effects 0.000 description 2
• 239000003531 protein hydrolysate Substances 0.000 description 2
• 238000003127 radioimmunoassay Methods 0.000 description 2
• 238000005215 recombination Methods 0.000 description 2
• 230000000717 retained effect Effects 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 238000013341 scale-up Methods 0.000 description 2
• 230000003584 silencer Effects 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 230000000638 stimulation Effects 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 230000001988 toxicity Effects 0.000 description 2
• 231100000419 toxicity Toxicity 0.000 description 2
• 231100000440 toxicity profile Toxicity 0.000 description 2
• 230000001960 triggered effect Effects 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• 108700026220 vif Genes Proteins 0.000 description 2
• 230000009385 viral infection Effects 0.000 description 2
• 230000017613 viral reproduction Effects 0.000 description 2
• 229940023147 viral vector vaccine Drugs 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• CDKIEBFIMCSCBB-UHFFFAOYSA-N 1-(6,7-dimethoxy-3,4-dihydro-1h-isoquinolin-2-yl)-3-(1-methyl-2-phenylpyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one;hydrochloride Chemical compound Cl.C1C=2C=C(OC)C(OC)=CC=2CCN1C(=O)C=CC(C1=CC=CN=C1N1C)=C1C1=CC=CC=C1 CDKIEBFIMCSCBB-UHFFFAOYSA-N 0.000 description 1
• BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
• 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
• 102100023635 Alpha-fetoprotein Human genes 0.000 description 1
• 101710145634 Antigen 1 Proteins 0.000 description 1
• 102000006306 Antigen Receptors Human genes 0.000 description 1
• 108010083359 Antigen Receptors Proteins 0.000 description 1
• 241000269350 Anura Species 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• 241001443586 Atadenovirus Species 0.000 description 1
• 241000701802 Aviadenovirus Species 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 102100022970 Basic leucine zipper transcriptional factor ATF-like Human genes 0.000 description 1
• 102100027314 Beta-2-microglobulin Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 101000964894 Bos taurus 14-3-3 protein zeta/delta Proteins 0.000 description 1
• 108700016947 Bos taurus structural-GP Proteins 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 108090000342 C-Type Lectins Proteins 0.000 description 1
• 102000003930 C-Type Lectins Human genes 0.000 description 1
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 102000008203 CTLA-4 Antigen Human genes 0.000 description 1
• 102100029761 Cadherin-5 Human genes 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102100029968 Calreticulin Human genes 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
• 208000005623 Carcinogenesis Diseases 0.000 description 1
• 108090000397 Caspase 3 Proteins 0.000 description 1
• 102100026549 Caspase-10 Human genes 0.000 description 1
• 102100029855 Caspase-3 Human genes 0.000 description 1
• 102100038918 Caspase-6 Human genes 0.000 description 1
• 102100038902 Caspase-7 Human genes 0.000 description 1
• 102100026548 Caspase-8 Human genes 0.000 description 1
• 241000701489 Cauliflower mosaic virus Species 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 241000282693 Cercopithecidae Species 0.000 description 1
• 108010058699 Choline O-acetyltransferase Proteins 0.000 description 1
• 108700010070 Codon Usage Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 102000000529 Costimulatory and Inhibitory T-Cell Receptors Human genes 0.000 description 1
• 108010041504 Costimulatory and Inhibitory T-Cell Receptors Proteins 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• 108010037897 DC-specific ICAM-3 grabbing nonintegrin Proteins 0.000 description 1
• 108010041986 DNA Vaccines Proteins 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 101100481408 Danio rerio tie2 gene Proteins 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 101100202589 Drosophila melanogaster scrib gene Proteins 0.000 description 1
• 206010059866 Drug resistance Diseases 0.000 description 1
• 101150029662 E1 gene Proteins 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 241000196324 Embryophyta Species 0.000 description 1
• 102100037241 Endoglin Human genes 0.000 description 1
• 108010036395 Endoglin Proteins 0.000 description 1
• 102100038083 Endosialin Human genes 0.000 description 1
• 101710144543 Endosialin Proteins 0.000 description 1
• 102400000686 Endothelin-1 Human genes 0.000 description 1
• 101800004490 Endothelin-1 Proteins 0.000 description 1
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
• 241000283086 Equidae Species 0.000 description 1
• 241000283074 Equus asinus Species 0.000 description 1
• 101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
• 108700039887 Essential Genes Proteins 0.000 description 1
• 102100026693 FAS-associated death domain protein Human genes 0.000 description 1
• 102100027581 Forkhead box protein P3 Human genes 0.000 description 1
• 101710086299 Fructose-2,6-bisphosphatase Proteins 0.000 description 1
• 101150117028 GP gene Proteins 0.000 description 1
• 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 description 1
• 108060003393 Granulin Proteins 0.000 description 1
• 102100040754 Guanylate cyclase soluble subunit alpha-1 Human genes 0.000 description 1
• 102100040735 Guanylate cyclase soluble subunit alpha-2 Human genes 0.000 description 1
• 102100040739 Guanylate cyclase soluble subunit beta-1 Human genes 0.000 description 1
• 102100028963 Guanylate cyclase soluble subunit beta-2 Human genes 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 206010061192 Haemorrhagic fever Diseases 0.000 description 1
• 101150046249 Havcr2 gene Proteins 0.000 description 1
• 102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
• 101710100504 Heat shock protein beta-1 Proteins 0.000 description 1
• 101710154606 Hemagglutinin Proteins 0.000 description 1
• 101710133291 Hemagglutinin-neuraminidase Proteins 0.000 description 1
• 102100028008 Heme oxygenase 2 Human genes 0.000 description 1
• 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
• 108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 description 1
• 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102100035081 Homeobox protein TGIF1 Human genes 0.000 description 1
• 101000824278 Homo sapiens Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
• 101000903742 Homo sapiens Basic leucine zipper transcriptional factor ATF-like Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000793651 Homo sapiens Calreticulin Proteins 0.000 description 1
• 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
• 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
• 101000983518 Homo sapiens Caspase-10 Proteins 0.000 description 1
• 101000741087 Homo sapiens Caspase-6 Proteins 0.000 description 1
• 101000741014 Homo sapiens Caspase-7 Proteins 0.000 description 1
• 101000983528 Homo sapiens Caspase-8 Proteins 0.000 description 1
• 101001010910 Homo sapiens Estrogen receptor beta Proteins 0.000 description 1
• 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 1
• 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 1
• 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 description 1
• 101001038755 Homo sapiens Guanylate cyclase soluble subunit alpha-1 Proteins 0.000 description 1
• 101001038749 Homo sapiens Guanylate cyclase soluble subunit alpha-2 Proteins 0.000 description 1
• 101001038731 Homo sapiens Guanylate cyclase soluble subunit beta-1 Proteins 0.000 description 1
• 101001059095 Homo sapiens Guanylate cyclase soluble subunit beta-2 Proteins 0.000 description 1
• 101001079615 Homo sapiens Heme oxygenase 2 Proteins 0.000 description 1
• 101000596925 Homo sapiens Homeobox protein TGIF1 Proteins 0.000 description 1
• 101001003149 Homo sapiens Interleukin-10 receptor subunit beta Proteins 0.000 description 1
• 101000599048 Homo sapiens Interleukin-6 receptor subunit alpha Proteins 0.000 description 1
• 101000599056 Homo sapiens Interleukin-6 receptor subunit beta Proteins 0.000 description 1
• 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
• 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
• 101001091194 Homo sapiens Peptidyl-prolyl cis-trans isomerase G Proteins 0.000 description 1
• 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 description 1
• 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 1
• 101001068027 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Proteins 0.000 description 1
• 101001068019 Homo sapiens Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform Proteins 0.000 description 1
• 101000863882 Homo sapiens Sialic acid-binding Ig-like lectin 7 Proteins 0.000 description 1
• 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 description 1
• 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 description 1
• 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 description 1
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 1
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 description 1
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 1
• 101000652736 Homo sapiens Transgelin Proteins 0.000 description 1
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 1
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 1
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
• 101000922131 Homo sapiens Tyrosine-protein kinase CSK Proteins 0.000 description 1
• 101001135589 Homo sapiens Tyrosine-protein phosphatase non-receptor type 22 Proteins 0.000 description 1
• 101000617285 Homo sapiens Tyrosine-protein phosphatase non-receptor type 6 Proteins 0.000 description 1
• 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 description 1
• 101000926525 Homo sapiens eIF-2-alpha kinase GCN2 Proteins 0.000 description 1
• 108010048209 Human Immunodeficiency Virus Proteins Proteins 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• 101150062179 II gene Proteins 0.000 description 1
• 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 1
• 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 1
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
• 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 description 1
• 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 description 1
• 108020005350 Initiator Codon Proteins 0.000 description 1
• 108010064600 Intercellular Adhesion Molecule-3 Proteins 0.000 description 1
• 102100037871 Intercellular adhesion molecule 3 Human genes 0.000 description 1
• 108050006617 Interleukin-1 receptor Proteins 0.000 description 1
• 102000019223 Interleukin-1 receptor Human genes 0.000 description 1
• 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000010789 Interleukin-2 Receptors Human genes 0.000 description 1
• 108010038453 Interleukin-2 Receptors Proteins 0.000 description 1
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 1
• 108010025815 Kanamycin Kinase Proteins 0.000 description 1
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 241000282553 Macaca Species 0.000 description 1
• 241000701244 Mastadenovirus Species 0.000 description 1
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
• 101710202709 Middle T antigen Proteins 0.000 description 1
• 101710157639 Minor capsid protein Proteins 0.000 description 1
• 241000711513 Mononegavirales Species 0.000 description 1
• 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 1
• 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 1
• 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
• 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
• 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 1
• 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 108010008707 Mucin-1 Proteins 0.000 description 1
• 108010085220 Multiprotein Complexes Proteins 0.000 description 1
• 102000007474 Multiprotein Complexes Human genes 0.000 description 1
• MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
• 241001529936 Murinae Species 0.000 description 1
• 101100446506 Mus musculus Fgf3 gene Proteins 0.000 description 1
• 101100519207 Mus musculus Pdcd1 gene Proteins 0.000 description 1
• 101100481410 Mus musculus Tek gene Proteins 0.000 description 1
• 241000187488 Mycobacterium sp. Species 0.000 description 1
• 102000005604 Myosin Heavy Chains Human genes 0.000 description 1
• 108010084498 Myosin Heavy Chains Proteins 0.000 description 1
• 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
• KTHDTJVBEPMMGL-VKHMYHEASA-N N-acetyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(C)=O KTHDTJVBEPMMGL-VKHMYHEASA-N 0.000 description 1
• KTHDTJVBEPMMGL-UHFFFAOYSA-N N-acetyl-L-alanine Natural products OC(=O)C(C)NC(C)=O KTHDTJVBEPMMGL-UHFFFAOYSA-N 0.000 description 1
• 108091061960 Naked DNA Proteins 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 206010061309 Neoplasm progression Diseases 0.000 description 1
• 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
• 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
• 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 102100024894 PR domain zinc finger protein 1 Human genes 0.000 description 1
• 241000282577 Pan troglodytes Species 0.000 description 1
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 108010013639 Peptidoglycan Proteins 0.000 description 1
• 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 108010009975 Positive Regulatory Domain I-Binding Factor 1 Proteins 0.000 description 1
• 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 1
• 102100035703 Prostatic acid phosphatase Human genes 0.000 description 1
• 101710176177 Protein A56 Proteins 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 101710136297 Protein VP2 Proteins 0.000 description 1
• 101710150114 Protein rep Proteins 0.000 description 1
• 101710185720 Putative ethidium bromide resistance protein Proteins 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108700005075 Regulator Genes Proteins 0.000 description 1
• 241001068295 Replication defective viruses Species 0.000 description 1
• 101710152114 Replication protein Proteins 0.000 description 1
• 206010038997 Retroviral infections Diseases 0.000 description 1
• 108010083644 Ribonucleases Proteins 0.000 description 1
• 102000006382 Ribonucleases Human genes 0.000 description 1
• 101000767160 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Intracellular protein transport protein USO1 Proteins 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 102000012479 Serine Proteases Human genes 0.000 description 1
• 108010022999 Serine Proteases Proteins 0.000 description 1
• 102100034464 Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform Human genes 0.000 description 1
• 102100034470 Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform Human genes 0.000 description 1
• 241000620568 Siadenovirus Species 0.000 description 1
• 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 description 1
• 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 1
• 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• 102100037942 Suppressor of tumorigenicity 14 protein Human genes 0.000 description 1
• 101000987219 Sus scrofa Pregnancy-associated glycoprotein 1 Proteins 0.000 description 1
• 101001045447 Synechocystis sp. (strain PCC 6803 / Kazusa) Sensor histidine kinase Hik2 Proteins 0.000 description 1
• 108010008038 Synthetic Vaccines Proteins 0.000 description 1
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 1
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 description 1
• 102100035268 T-cell surface protein tactile Human genes 0.000 description 1
• 108091007178 TNFRSF10A Proteins 0.000 description 1
• 108091036066 Three prime untranslated region Proteins 0.000 description 1
• 102100031013 Transgelin Human genes 0.000 description 1
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 1
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 1
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 1
• 102100039094 Tyrosinase Human genes 0.000 description 1
• 108060008724 Tyrosinase Proteins 0.000 description 1
• 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 description 1
• 102100033138 Tyrosine-protein phosphatase non-receptor type 22 Human genes 0.000 description 1
• 102100021657 Tyrosine-protein phosphatase non-receptor type 6 Human genes 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 241000700618 Vaccinia virus Species 0.000 description 1
• 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
• 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 241001115400 Zaire ebolavirus Species 0.000 description 1
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
• 230000035508 accumulation Effects 0.000 description 1
• 238000009825 accumulation Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000033289 adaptive immune response Effects 0.000 description 1
• 229960005305 adenosine Drugs 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 210000001552 airway epithelial cell Anatomy 0.000 description 1
• 102000007362 alpha-Crystallins Human genes 0.000 description 1
• 108010007908 alpha-Crystallins Proteins 0.000 description 1
• 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
• 125000000539 amino acid group Chemical group 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 239000005557 antagonist Substances 0.000 description 1
• 230000036436 anti-hiv Effects 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 108010081355 beta 2-Microglobulin Proteins 0.000 description 1
• 238000001574 biopsy Methods 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000011496 cAMP-mediated signaling Effects 0.000 description 1
• 108010018828 cadherin 5 Proteins 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 230000036952 cancer formation Effects 0.000 description 1
• FFQKYPRQEYGKAF-UHFFFAOYSA-N carbamoyl phosphate Chemical compound NC(=O)OP(O)(O)=O FFQKYPRQEYGKAF-UHFFFAOYSA-N 0.000 description 1
• 150000001720 carbohydrates Chemical class 0.000 description 1
• 235000014633 carbohydrates Nutrition 0.000 description 1
• 231100000504 carcinogenesis Toxicity 0.000 description 1
• 230000034303 cell budding Effects 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 230000002759 chromosomal effect Effects 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 238000000975 co-precipitation Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000002648 combination therapy Methods 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 239000003636 conditioned culture medium Substances 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 238000002784 cytotoxicity assay Methods 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 229960003957 dexamethasone Drugs 0.000 description 1
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 102100034175 eIF-2-alpha kinase GCN2 Human genes 0.000 description 1
• 238000004520 electroporation Methods 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 210000003527 eukaryotic cell Anatomy 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 230000002496 gastric effect Effects 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 108091006104 gene-regulatory proteins Proteins 0.000 description 1
• 231100000024 genotoxic Toxicity 0.000 description 1
• 230000001738 genotoxic effect Effects 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 230000035931 haemagglutination Effects 0.000 description 1
• 201000010536 head and neck cancer Diseases 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 229910001385 heavy metal Inorganic materials 0.000 description 1
• 239000000185 hemagglutinin Substances 0.000 description 1
• 230000001744 histochemical effect Effects 0.000 description 1
• 230000005745 host immune response Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 239000000411 inducer Substances 0.000 description 1
• 206010022000 influenza Diseases 0.000 description 1
• 208000037798 influenza B Diseases 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 108091008042 inhibitory receptors Proteins 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 239000012212 insulator Substances 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 210000004347 intestinal mucosa Anatomy 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 230000021633 leukocyte mediated immunity Effects 0.000 description 1
• 150000002632 lipids Chemical class 0.000 description 1
• 238000001638 lipofection Methods 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 210000004698 lymphocyte Anatomy 0.000 description 1
• 239000006166 lysate Substances 0.000 description 1
• 210000003712 lysosome Anatomy 0.000 description 1
• 230000001868 lysosomic effect Effects 0.000 description 1
• 230000002101 lytic effect Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 238000012737 microarray-based gene expression Methods 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 238000000520 microinjection Methods 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 231100000324 minimal toxicity Toxicity 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 238000012243 multiplex automated genomic engineering Methods 0.000 description 1
• 239000003471 mutagenic agent Substances 0.000 description 1
• 229940022007 naked DNA vaccine Drugs 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 231100001079 no serious adverse effect Toxicity 0.000 description 1
• 244000309711 non-enveloped viruses Species 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 210000003101 oviduct Anatomy 0.000 description 1
• 230000001717 pathogenic effect Effects 0.000 description 1
• 230000007918 pathogenicity Effects 0.000 description 1
• 108010031345 placental alkaline phosphatase Proteins 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000002265 prevention Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 238000011809 primate model Methods 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 229940021993 prophylactic vaccine Drugs 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 108010043671 prostatic acid phosphatase Proteins 0.000 description 1
• 210000001938 protoplast Anatomy 0.000 description 1
• 150000003248 quinolines Chemical class 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 229940124551 recombinant vaccine Drugs 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000033458 reproduction Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000035945 sensitivity Effects 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 238000003153 stable transfection Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 230000002459 sustained effect Effects 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 229940037128 systemic glucocorticoids Drugs 0.000 description 1
• 101150098170 tat gene Proteins 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 230000017105 transposition Effects 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 230000005751 tumor progression Effects 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241001529453 unidentified herpesvirus Species 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 229960005356 urokinase Drugs 0.000 description 1
• 229940125575 vaccine candidate Drugs 0.000 description 1
• 230000006490 viral transcription Effects 0.000 description 1
• 108010047303 von Willebrand Factor Proteins 0.000 description 1
• 102100036537 von Willebrand factor Human genes 0.000 description 1
• 229960001134 von willebrand factor Drugs 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1